Controversies in stable coronary artery disease

This publication has 111 references indexed in Scilit:

• Exercise Prescription and Proscription for Patients With Coronary Artery Disease
  Circulation, 2005
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
  The Lancet, 2005
• Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta–Null Genotype
  Circulation, 2005
• Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
  Hypertension, 2005
• ACE Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2005
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2004
• Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
  American Heart Journal, 2004
• Long-term outcomes of optimized medical management of outpatients with stable coronary artery disease
  The American Journal of Cardiology, 2004
• A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes
  JACC, 2003
• Cardiovascular disease risk profiles
  American Heart Journal, 1991